#GUTOnline #RecentAdvancesInBasicScience paper by Barnich et al entitled "Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary" via bit.ly/3SIjI4k #CrohnsDisease #Ecoli

🦠 EAEC in Crohn’s disease (entero adherent E. coli) gut.bmj.com/content/early/…

#GUTImage from the paper by Guisado et al entitled "Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease" via bit.ly/438XpJy Ling-shiang (Felix) Chuang, Ph.D. Mount Sinai Division of Gastroenterology #IBD #CrohnsDisease

🚨 ENROLLING 🚨 Active Mount Sinai IBD Center study to evaluate the safety and efficacy of FMT from patients with a normal pouch to patients with chronic pouchitis. Help us the change the way we manage chronic pouchitis! Patients on biologics or small molecules eligible!

We are excited to present our recent virtual discussion with Dr. Joana Torres, who brings us up to date on the latest in #IBD prediction and prevention! She shares with us the remarkable headway that researchers are making in predicting disease risk years before onset, as

#GUTOnline #RecentAdvancesInBasicScience paper by Barnich et al entitled "Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary" via bit.ly/3SIjI4k #CrohnsDisease #Ecoli

What if we could detect IBD years before symptoms start? Our Chief Scientific Officer, Dr. Alan Moss, shares breakthrough research on early detection and prevention that could change the future for millions of people. Don’t miss this must-read blog—find out how prevention is

Negative = positive in terms of insight into #microbiome & #crohnsdisease. Mark Pimentel MD Crohn's & Colitis Foundation ACG

#GUTOnline #RecentAdvancesInBasicScience paper by Barnich et al entitled "Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary" via bit.ly/3SIjI4k #CrohnsDisease #Ecoli

Congrats to Palak Rajauria on winning “Best Research Presentation” at this year’s IBD Retreat! Her work with Dr. Ryan Ungaro’s team shows a blood test may predict #CrohnsDisease up to 2 years before diagnosis with 99% specificity: wb.md/3ZZ8rk6 Ryan Ungaro MD MS Mount Sinai Department of Medicine

So often forgotten and never considered in clinical trials Elephant in the room !! Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion - PubMed pubmed.ncbi.nlm.nih.gov/40587340/

🚨 Scrotal swelling in a patient with Crohn’s disease: More than meets the eye 👀 Grateful to Jean-Frederic Colombel for the mentorship and shared curiosity! Time to revisit the lymphatics in CD? 🤔 Out now in Gastroenterology gastrojournal.org/article/S0016-… Mount Sinai Division of Gastroenterology Mount Sinai IBD Center

Utilizing a prospective pre-disease cohort, Research Letter reveals that early #Epstein-Barr virus exposure could significantly increase the risk of developing #CrohnsDisease. Learn more at ow.ly/MHSJ50WlMC4 #EBV #IBD

#GUTOnline #RecentAdvancesInBasicScience paper by Barnich et al entitled "Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary" via bit.ly/3SIjI4k #CrohnsDisease #Ecoli

When science 🧫 has an impact in patients. Proud of this important step in testing our scientific discoveries in a clinical study 👩‍🔬 Only possible with a truly bench to bedside approach in collaboration with Joana Torres Towards #IBD prevention i3S-Instituto de Investigação e Inovação em Saúde GlycanTrigger

🚨The Risk of Mild, Moderate and Severe Infections in #IBD – Prospective multicentre cohort study (PRIQ) 📌Understudied topic 💎In 629 pts, we found mild & moderate infections are common & linked to key risk factors (steroids doubled the risk👀) Journal of Crohn's and Colitis doi.org/10.1093/ecco-j…

We’re proud to be recognized among the top global universities by U.S. News & World Report—a testament to our commitment to excellence across education, research, and clinical care. The Icahn School of Medicine at Mount Sinai also ranked in the top 5 worldwide for both Cardiac

Dr. Saurabh Mehandru of Mehandru Lab @MountSinai Icahn School of Medicine at Mount Sinai is presenting on B cell dysfunction in inflammatory bowel diseases. #InnovationsSymposium2025

Shrinivas Bishu Tauseef Ali MD, FACG AGAF FACP Aline Charabaty, MD, FACG, AGAF Tina Aswani-Omprakash, MPH Shubha Bhat, PharmD Beatriz Gros Michael Chiorean May be unpopular view : I do have concerns that when most of the world can’t afford to even reach clinical & biomarker remission ( and actually live and work ) , we are pushing the boat with advanced therapies one after the other and ‘striding’ to higher targets with limited

Join us for the 3rd Annual Nutrition & IBD Education Session to learn about UPFs, surgical nutrition optimization, obesity and GLP1s, diet & IBD prevention, and nutrition for patients with IBS & IBD. Registration below! jotform.com/form/223194548…